Objective: To develop and validate a scale to measure patients' trust in pharmacists for use as an outcomes predictor in pharmacoeconomic and pharmaceutical care studies. Methods: Literature review, study team discussion and focus group discussions were conducted to generate items of a candidate version to be pilot-tested for content validity. An amended candidate version was then tested among eligible Singaporeans across different ethnic and age groups. Score distributions were assessed for discriminatory power and item analyses for fi nalizing items. Exploratory factor analysis was used to identify dimensionality and homogeneous items. Cronbach's alpha was measured for internal consistency and Pearson's correlation coeffi cients for convergent validity. Results: Eighteen items were generated with good variability (SD Ͼ 1.0) and symmetry (means ranged from −1 to 1) for score distribution. After minor changes to improve content clarity, the amended questionnaire was self-administered among 1196 respondents [mean (SD) age: 38.6 (14.9) years, 51.6% female, 87% Ͼ6 years of education]. Six items were dropped due to inadequate item-total correlation coeffi cients, leaving 12-item scale for factor analysis. Three factors ("benevolence", "technical competence" and "global trust") were identifi ed, accounting for 55% of the total variance. Cronbach's alpha was 0.83, indicating high internal consistency. Convergent validity was demonstrated by statistically signifi cant positive correlations between trust and patients' satisfaction with pharmacists' service (r = 0.54), returning for care (r = 0.30) and preference of medical decision-making pattern (r = 0.16).
Introduction
With the increasing emphasis on pharmaceutical care in the practice of pharmacy, the roles of pharmacists have been undergoing vigorous expansion. Studies have shown that pharmaceutical care contributed to less drug-related morbidities and mortalities, improved clinical outcomes and health-related quality of life, and lower medical costs. [1] [2] [3] A key success factor in the pharmaceutical care is the quality of patientpharmacist relationship. In such relationship, patients grant authority to pharmacists to manage their health and well-being. In turn, pharmacists accept responsibility to take care of the well-being of the patients. 1, 4 Because of the vulnerability of patients and uncertainties of outcomes, patient-pharmacist relationship is largely infl uenced by the level of patients' trust in pharmacists. 5 From the patients' perspective, trust in pharmacists could be defi ned as "patients' willingness to be vulnerable to the actions of pharmacists based on the expectation that pharmacists will do what is best for patients, irrespective of patients' ability to monitor pharmacists." 6 Based on a literature search in PubMed (1966 ( -Oct 2006 , there was no published scale to measure patients' trust in pharmacists. In order to assess infl uence of trust on other outcomes (ie, adherence to drug therapy, satisfaction with the pharmacy service, quality of pharmaceutical care, etc.) as demonstrated in studies on other medical practitioners, a reliable and valid instrument to test patients' trust in pharmacists should be developed fi rst. [7] [8] [9] Therefore, the primary objective of this study was to develop and validate a scale that could measure patients' trust in pharmacists.
As for the scale development, although practical patterns are different between pharmacists and other health care practitioners, items and dimensions in trust scales of other health care practitioners could still provide useful references. It was found that items in the other trust scales could be summed into two overarching dimensions as technical competence and benevolence. 10, 11 Technical competence might include evaluating problems thoroughly, providing appropriate and effective treatment, predisposing factors and structural and staffi ng factors. Benevolence dimension might comprise understanding patients' individual experiences, expressing caring, communicating clearly and completely, building partnership and sharing power, demonstrating honesty and respect, and keeping information confi dential. 8, [10] [11] [12] [13] In the process of validation, three hypotheses were generated to test the convergent validity of the scale based on fi ndings from studies on the relationships between patients and physicians/other health care practitioners: 8, 10, 11, 14 1) Patients' trust in pharmacists would be positively correlated with "satisfaction with pharmacists' service"; 2) Patients' trust in pharmacists would be positively correlated with "returning for care"; 3) Patients' trust in pharmacists would be positively correlated with "preference of having pharmacists to decide on the medication to buy".
Methods

Study design and subjects
The whole study was divided into two phases: scale development and scale validation. No fi nancial compensation was given to any participants in this study and ethics approval for the study was obtained from the National University of Singapore.
Scale development
Literature review on trust scales in other health care professions and further study team discussion were carried out to identify or generate candidate domains and items that might be used to develop the trust scale in pharmacists. Focus group approach was then used to determine whether the concept, the candidate domains and items based on the literature review and study team discussion were relevant, and to explore any new candidate domains or items. Apart from the open discussion, quantitative methods were also used to explore the relevance of those candidate items identifi ed or generated from the literature review and the study team discussion. Respondents were asked to rate the relevance of those domains and items on a 5-point Likert Scale (1 = least relevant, 5 = most relevant). Eligible participants for the focus group discussion were recruited from the batch of fi nal-year pharmacy undergraduates at the National University of Singapore, who had consulted and obtained medications from pharmacists during the past six months before the discussion. The rationale to recruit fi nal-year pharmacy undergraduate students as focus group participants was that their valuable experience as intern pharmacists could add in the perspective from pharmacists as well as third-party observers.
In accordance with rules of thumb, a sample of three to four groups with seven people each was planned initially. The exact number of groups was determined by the reaching of "saturation point". 15 The saturation point was decided to be reached if there was no more information/data generated from the last two focus group discussions. Focus group discussions were audio-recorded and transcribed for content analysis using ATLAS.ti 5.0 Demo (ATLAS.ti Scientifi c Software Development GmBh, Berlin, 2003 Berlin, -2005 .
Based on the results of the focus group discussions, the candidate version of "Trust in Pharmacists Scale" was developed. The scale was structured with both favorably and unfavorably worded items to avoid respondents' blind agreement with statements regardless of the content. 16 Answers were formatted with a 7-point Likert scale (with −3 = totally disagree and 3 = totally agree) to improve score distribution. 17 Scores of individual items could be summed up for a fi nal score to represent the level of patients' trust in pharmacists.
The candidate scale was evaluated by 10 other pharmacy graduate students for face validity (the relevance to measure "patients' trust in pharmacists") and clarity of those candidate items. An expert panel of three experienced pharmacists was asked to assess content validity, that is, how well the candidate items represented the specifi c intended domains based on experts' judgment. 18 Pilot testing of the revised candidate version was undertaken by a convenience sample of another 77 fi nal-year pharmacy undergraduates, who had not participated in the focus group discussion. Time of completion, comments on the revised candidate scale were also collected Trust in pharmacists scale to ensure nonexcessive burden on the respondents and to provide further suggestions on item modifi cations.
Scale validation
After necessary amendments, the fi nalized candidate scale was aimed to be distributed by research assistants to a convenience sample of 1,200 English-speaking Singaporeans at local neighbourhoods and community centers. It was designed that study subjects should be across the three major local ethnic groups (Chinese, Malay and Indian) from three age groups (18-35 yrs; 36-55 yrs; 56 yrs and above) with an equal ratio among ethnic groups and 2:2:1 ratio among age groups to explore factor structure, reliability and validity of the questionnaire. The uneven ratio of age groups was due to the fact that the English-speaking elderly population is relatively small in Singapore. 19 Besides, some of the elderly English-speaking population might also have cognitive dysfunction due to medical problems or the aging process.
Eligible respondents should be able to complete the English questionnaire without any help and have consulted or obtained medications from a pharmacist during the past six months.
Measures
Besides the fi nalized candidate scale to measure patients' trust in pharmacists, several other questions were included in the questionnaire: demographic information (age, gender, ethnicity, housing, education level); current chronic disease status, basic information relevant to the scale (time period of last visit to a pharmacist; type of pharmacist visited last time); a validated six-item scale to assess patients' satisfaction with the pharmacists' service; 17 and two newly-generated items based on the demonstrated positive association as in earlier literatures to assess the behavior intents (willingness to return for care on the 7-point Likert scale, preferred decisionmaking pattern on medication on a 5-point Likert scale [1 = totally by myself, 5 = totally by pharmacist]).
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Statistical analysis Scale development
In the scale development, item means and standard deviations were used to quantitatively measure the relevance of those candidate items generated from literature review and study team discussion by the focus group participants. Item means and standard deviations were also used to determine whether adequate variability and symmetry in score distribution were achieved in the revised candidate scale.
Scale validation
In the scale validation, sample characteristics were descriptively analyzed. Response means and standard deviation were calculated to determine variability and symmetry in score distributions, which could indicate discriminatory power. To select items for the fi nal scale, item analyses were done to ensure the corrected item-total correlation coeffi cients should be greater than 0.30 for fi nal items. 22 Exploratory factor analysis was used to determine dimensions of the trust. Principal components analysis of the partial correlation matrix was used to identify groups of homogeneous items suitable for measuring each dimension of the trust. The number of factors selected for Varimax rotation was determined by a combination of criteria: (1) the roots criterion of selecting factors with eigenvalues to be greater than 1; (2) the Scree test to examine a plot of eigenvalues and stop factoring at the point where the pot begins to level off; and (3) the interpretability and meaningfulness of trial factor rotations. Each factor should have two or more loadings above 0.40 to make a rotated factor interpretable. In addition, the items loading on one factor should fi t together logically. [23] [24] [25] [26] Tentative scale was then composed of those items with factor loading above 0.40 on one factor and lesser loadings on other factors to represent each dimension. If an item loaded above 0.40 on more than one factor, assignment of the item was to be based on logical fi t and verifi cation by item analysis. 22, 23, 25 As for reliability, internal consistency was assessed by Cronbach's alpha. Convergent validity was studied using Pearson's correlation coeffi cients to indicate the association between "patients' trust in pharmacists" with "patients' satisfaction with pharmacists' service", "willingness to return for care" and "preferred decision-making pattern on medication".
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Results
Scale development
Altogether four focus groups (total number of participants = 28) were shown to be adequate for item generation. Table 1 presents the eighteen candidate items that were identifi ed in the literature review, the study team and the focus group discussions. It was found that most of the candidate items generated from the focus group discussion were the same as those identifi ed from the literature review and the study team discussion. Results showed that age, gender, ethnicity of pharmacist might be less relevant to patients' predisposing trust in pharmacists than the rest of the items. There were two brand new items generated from the focus group discussions: type of the pharmacist and set-up of the pharmacy counter. Some of the participants thought aloud that they preferred hospital pharmacists due to their rich experience with various illnesses. Additionally, "a neat and tidy pharmacy counter" was regarded as a refl ection of professionalism and effi ciency of pharmacists. Based on literature review, another item on global trust was also included (Item 18 in Table 1 ).
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The questionnaire was assessed as face valid by the pharmacy postgraduate students and as content valid by the expert panel of pharmacists. In the pilot test, the average completion time was 7.4 minutes. Score distribution of the 18 candidate items was shown to achieve good variability (SD Ͼ 1.0) and symmetry (means ranged from −1 to 1) . In the open-ended question on readability of the questionnaire, quite a few respondents suggested to avoid using negative worded items so as to minimize confusion. Except for some minor wording changes, no other problems were raised. After minor revisions, the scale to be validated included 18 revised candidate items ( Table 2) .
Scale validation
Altogether 2,965 people were approached for the study, yet 1,759 of them declined to participate. In the end, the questionnaires were distributed to 1,206 eligible respondents (response rate = 41%). Data analysis was based on 1,196 respondents with complete answers on all 18 candidate items of the trust scale. Demographic and background information was summarized in Table 3 .
Item analyses (Table 2) showed that fi ve candidate items (Items 4, 11, 13, 14, and 15) were below the criteria of 0.3 in item-total correlation, so they were dropped in the fi rst round. When the 13 candidate items were performed using the same analysis again, item 10 was found to be below the criteria (coeffi cient = 0.12 Ͻ0.3), leaving 12 items for subsequent analyses. 22 Based on the criteria of eigenvalue and Scree plot, three factors were identifi ed that accounted for 55% of the total variance with the fi rst factor explaining up to 36%. Two items (Items 3 and 5) had dual loadings (loadings greater than 0.40 on two factors). Scale assignments for them were made on the basis of logical fi t with other items loading on the two factors under consideration. Table 4 lists the factor loading and assignment of the 12 fi nal items. Notes: *1 = generated from focus group only; 2 = generated from literature review only; 3 = both 1 and 2; 4 = generated by the study team only; **Relevance is scored on a 5-point Likert scale (1 = most irrelevant; 2 = somewhat irrelevant; 3 = neutral; 4 = somewhat relevant; 5 = most relevant) from 28 participants. Data is presented as mean (SD); N/A, not applicable.
Trust in pharmacists scale
Factors were labeled as follows according to the order of extraction: (1) benevolence (including six candidate items: confi dentiality, expressing caring, communicating clearly and completely, showing suffi cient respect, providing effective medication at a reasonable price and allowing shared decision-making pattern when there are alternatives); (2) technical competence (including two candidate items: demonstrating up-to-date knowledge and evaluating medical problem thoroughly); and (3) global trust including all other aspects that do not exclusively fi t in any dimension (including four candidate items: blind trust in pharmacists and predisposing factors such as recommendation by others, set-up of pharmacy counter and professional appearance). 8, [10] [11] [12] [13] Due to the observation that the correlation coeffi cients among three factors via Promax rotation were all less than 0.5, discriminatory power was demonstrated and a threedimension scale structure was suggested. 24 As shown in Table 4 , item-scale correlation coeffi cients were between 0.35 and 0.60. The Cronbach's alpha was 0.83, indicating high internal consistency. 27 Convergent validity was demonstrated by the fi nding that, as hypothesized, patients' trust in pharmacists was positively correlated with patients' satisfaction with pharmacists' service (r = 0.54, P Ͻ 0.001), returning for care (r = 0.30, P Ͻ 0.001) and preference of having pharmacists to decide on the medication to buy (r = 0.16, P Ͻ 0.001).
Discussion
To the best of our knowledge, the current study was the fi rst one to develop and validate a scale to measure patients' trust in pharmacists. The availability of such scale will enable the incorporation of "patients' trust in pharmacists" as a dependent or an independent variable in pharmacoeconomics and pharmaceutical care studies in various health care settings. The 12-item scale developed in this study demonstrated high reliability and good convergent validity. Systematic approach has been adopted to ensure robustness of the results. Scale development included item generation (by literature review, study team discussion and focus group approach) and item refi nement (by panel review and pilot test). Scale validation was performed by response analysis, reliability and validity tests, and exploratory factor analysis. Interestingly, the scale to measure patients' trust in pharmacists was shown to have similar dimensionalities to the scale to measure patients' trust in physicians. The two common dimensionalities were technical competence and benevolence. This would imply that patients tend to trust health care providers based on similar criteria. If so, health care providers should especially put their efforts in improving technical competence and showing benevolence to achieve desired treatment outcomes. 26 Apart from the similarity, a difference was also detected in the assignment of global trust. Global trust was identifi ed as an independent factor based on the exploratory factor analysis in the current scale. Yet, in the scale to measure patients' trust in physicians, it was incorporated into the benevolence factor. 11 Additionally, the positive correlations as reported in the fi ndings of convergent validity merit some further discussion. It is important and interesting for pharmacists to know that trust did play an important part in patients' satisfaction with their services (r = 0.54, p Ͻ 0.001). As patients' satisfaction has been increasingly emphasized to measure the quality of pharmaceutical care, it is thus essential for pharmacists to understand how to gain and improve patients' trust, which could actually be assisted with the use of the current scale. 17 Similarly, although the correlation between trust and chances of returning for care was only mild (r = 0.30, p Ͻ 0.001), yet it did suggest that trust would infl uence the long-term relationship between pharmacists and patients, which has become increasingly important in chronic disease management. Comparatively, the correlation between trust in pharmacists and preference of having pharmacists to make the medication decision tended to be much milder. This might in fact suggest that patients, especially younger generations, might prefer a shared decision-making pattern by pharmacists and themselves. This changing paradigm actually fi t one of the objectives of disease management, that is, patients themselves should play a critical role and be more medically knowledgeable. Several limitations together with suggestions for future studies should also be noted:
First, because patients' trust is a changeable psychological trait and not a steady state, retest was not carried out in our study. 9, 28 Therefore, test-retest reliability remains unknown for the scale. We suggest that test-retest reliability test be assessed in future studies to prove the robustness of the scale. In order to minimize the potential change in this psychological trait, we suggest the interval of test-retest should be relatively short (eg, one to two weeks) and the participant should not have interacted with any other pharmacist during the interval. Otherwise, the participant should be excluded from the test-retest reliability analysis.
Second, despite potential advantages of thinking of trust in perspectives of both patients and pharmacists, fi nal-year pharmacy undergraduates may not well represent pharmacyvisiting patients in the real world. Hence, it is possible that the items generated from those undergraduates might be different from patients with diversifi ed backgrounds. Hence, this may potentially affect the validity of the current scale. We suggest that in future studies patients with diversifi ed backgrounds be recruited in the focus group discussions to further validate the current scale.
Third, due to the convenience sampling and selfadministration mode, respondents of the current study might be healthier and better educated compared with the average level of pharmacy-visiting patients. Such potential bias may lead to different emphasis on the items of trust in pharmacists, which may lead to somewhat different chosen items. Hence, it is suggested that future study be sampled on a more general population to further validate the scale.
In conclusion, the 12-item scale to measure patients' trust in pharmacists demonstrated high reliability and convergent validity. It was constructed on three factors, namely, benevolence, technical competence and global trust. Further studies with a larger and diverse sample are suggested to confi rm the robustness or even improve the scales. Nevertheless, the current scale would provide at least a viable prototype for further development of a universally accepted scale to measure patients' trust in pharmacists.
